Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
Cleveland Clinic is consistently recognized in the U.S
Importantly for MCS, the two receptors modulate and sensitize each other
Stimulates Lipolysis Prompts fat cells to break stored triglycerides into free fatty acids the body can burn for fuel Inhibits Lipogenesis Slows the creation of new fat, working both sides of the fat-storage equation No IGF-1 Rise Isolates the fat-metabolism fragment, so it does not raise IGF-1 or drive tissue growth No Glucose Disruption In studies it did not impair insulin sensitivity or affect blood sugar the way full GH can In laboratory and animal work, the fragment behaved as designed
Stacked Protocol (Cagrilintide + Smglutd) Dose: 0.6 2.4 mg Cagrilintide + 0.25 2.4 mg Smglutd (= 2496 clicks) Duration: 12 20 weeks Frequency: Once weekly, co-administered Cycle Interval: 4 6 weeks off before repeating Goal / Description: Dual amylin and GLP-1 receptor activation studied for enhanced metabolic and weight outcomes
